Court Place Advisors, LLC Ligand Pharmaceuticals Inc Transaction History
Court Place Advisors, LLC
- $307 Million
- Q4 2024
A detailed history of Court Place Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Court Place Advisors, LLC holds 5,783 shares of LGND stock, worth $644,168. This represents 0.2% of its overall portfolio holdings.
Number of Shares
5,783
Previous 13,483
57.11%
Holding current value
$644,168
Previous $1.35 Million
54.15%
% of portfolio
0.2%
Previous 0.4%
Shares
23 transactions
Others Institutions Holding LGND
# of Institutions
269Shares Held
18.4MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$320 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$232 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$112 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$98.8 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX723KShares$80.5 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.88B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...